Galectin Therapeutics, Inc. (GALT)
2.45
+0.05
(+2.08%)
USD |
NASDAQ |
Jun 09, 15:19
Galectin Therapeutics EPS Diluted (Quarterly) : -0.077 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Savara, Inc. | -0.1472 |
| Vericel Corp. | -0.1241 |
| Biogen, Inc. | 2.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.046M |
| Total Expenses (Quarterly) | 5.046M |
| Enterprise Value | 281.86M |
| Earnings Yield | -16.73% |
| Normalized Earnings Yield | -15.59 |